Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”

Abstract Non-pharmaceutical interventions (NPI) for infectious diseases such as COVID-19 are particularly challenging given the complexities of what is both practical and ethical to randomize. We are often faced with the difficult decision between having weak trials or not having a trial at all. In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Noah A. Haber, Sarah E. Wieten, Emily R. Smith, David Nunan
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/acc80c986e95464cbc126642a8ed9314
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!